Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/28020
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGurgula, O-
dc.date.accessioned2024-01-15T17:32:43Z-
dc.date.available2024-01-15T17:32:43Z-
dc.date.issued2024-02-01-
dc.identifier.citationGurgula, O. (2024) 'On the European Commission’s proposal to create a new EU-wide compulsory licensing regime.', European Intellectual Property Review, 46 (2), pp. 70 - 77. Available at: https://uk.westlaw.com/Document/I15AE6E30B59D11EE8CAAD3B343E66021/View/FullText.html (accessed: 5 February 2024).en_US
dc.identifier.issn0142-0461-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/28020-
dc.description.abstractThis article discusses the European Commission’s proposal to implement a new EU-wide compulsory licensing regime and its key elements. The Commission’s proposal contains some novel and useful elements that may improve the effectiveness of compulsory licensing at the EU. This includes the possibility to issue a compulsory licence in relation to patent applications and SPCs, the indication of a generic name of a compulsory licensed medicine where the identification of all intellectual property rights or rights-holders requires time, the suspension of regulatory data and market protection, as well as access to confidential information and know-how. Moreover, while the proposal is focused on the use of compulsory licensing at the pan-European level, the approach taken by the Commission may also serve as an example for national compulsory licensing regimes in European and non-European countries making their mechanisms more flexible and effective. Such an approach may help to make the EU (and potentially other jurisdictions) better prepared for future national and global emergencies.en_US
dc.format.extent70 - 77-
dc.format.mediumPrint-Electronic-
dc.language.isoenen_US
dc.publisherSweet & Maxwell/ESC Publishingen_US
dc.relation.urihttps://uk.westlaw.com/Document/I15AE6E30B59D11EE8CAAD3B343E66021/View/FullText.html-
dc.rightsCopyright © Sweet & Maxwell/ESC Publishing 2024. This is a pre-copyedited, author-produced version of an article accepted for publication in Entertainment Law Review following peer review. The definitive published version E.I.P.R. 2024, 46 (X), YY-ZZ is available online on Westlaw UK: https://uk.westlaw.com/WestlawUK/Journals/Publications/European-Intellectual-Property-Review?skipAnonymous=true&transitionType=Default&contextData=(sc.Default)&firstPage=true (see: https://www.sweetandmaxwell.co.uk/terms/journals-access-policy.htm). It will is made available on this institutional repository under a CC BY-NC license. No commercial re-sue is permitted.-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.subjectcompulsory licensingen_US
dc.subjectthe European Commission’s proposalen_US
dc.subjectaccess to medicinesen_US
dc.subjectemergencyen_US
dc.subjectcrisisen_US
dc.subjectEUen_US
dc.subjectpatentsen_US
dc.subjectaccess to confidential informationen_US
dc.subjecttrade secretsen_US
dc.subjectpharmaceutical industryen_US
dc.titleOn the European Commission’s proposal to create a new EU-wide compulsory licensing regime.en_US
dc.typeArticleen_US
dc.relation.isPartOfEuropean Intellectual Property Review-
pubs.issue2-
pubs.publication-statusPublished-
pubs.volume46-
dc.rights.holderSweet & Maxwell/ESC Publishing-
Appears in Collections:Brunel Law School Embargoed Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfEmbargoed until 1 February 2025719.53 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons